Aarti Pharmalabs schedules its Q4 FY26 earnings conference call for investors and analysts on May 26, 2026.
The call will feature Chairman Rashesh Gogri, MD Hetal Gogri Gala, and CFO Piyush Lakhani.
The intimation is a regulatory disclosure made under SEBI LODR Regulation 30.
YES Securities is facilitating the call and provided a participant registration link.